Form 4: Select Medical CIO Granted 75,000 Restricted Shares

Select Medical Holdings Corp.'s Chief Information Officer, Brian R. Rusignuolo, was granted 75,000 shares of restricted common stock, vesting in 2028.

Summary

• Brian R. Rusignuolo, Chief Information Officer of Select Medical Holdings Corp. (SEM), was granted 75,000 shares of common stock.
• The transaction date for this grant is July 29, 2025.
• The shares were acquired at a price of $0, indicating a compensation grant rather than a purchase.
• Following this transaction, Mr. Rusignuolo's direct beneficial ownership of common stock totals 376,050 shares.
• The granted restricted stock will vest in full on July 29, 2028, which is the third anniversary of the grant date.

Sentiment

Score: 7

Explanation: A routine executive compensation grant, which is generally positive as it aligns executive interests with shareholders, but not a significant market-moving event on its own.

Positives

• The grant of 75,000 restricted shares to the Chief Information Officer aligns management's interests with long-term shareholder value.
• The three-year vesting schedule encourages long-term retention and performance from a key executive.

Future Outlook

The restricted stock grant is structured to vest fully on July 29, 2028, indicating a long-term incentive for the Chief Information Officer and a commitment to his continued service.

Industry Context

The grant of restricted stock to a key executive like the Chief Information Officer is a common practice across various industries, including healthcare services, to incentivize long-term performance and retain talent. It aligns the executive's financial interests with the company's long-term success and shareholder value creation.

Comparison to Industry Standards

• The grant of restricted stock with a multi-year vesting schedule is a standard executive compensation mechanism widely adopted by publicly traded companies, including peers in the healthcare services sector such as Encompass Health Corporation (EHC) or Kindred Healthcare (now part of Humana).
• This practice is consistent with market benchmarks for retaining and incentivizing senior leadership.

Stakeholder Impact

• Shareholders: Interests are further aligned with management due to the long-term equity incentive.
• Employees: May signal stability in leadership and a commitment to executive retention.

Next Steps

• The 75,000 restricted shares are scheduled to vest in full on July 29, 2028.

Key Dates

Recommendation

This Form 4 reports a standard restricted stock grant to a key executive, which is a common compensation practice designed to align management incentives with long-term shareholder value. It does not present new information that would fundamentally alter the investment outlook for Select Medical Holdings Corp., thus a 'hold' recommendation remains appropriate based solely on this filing.

Keywords

Select Medical, SEM, Restricted Stock, Stock Grant, Insider Transaction, Form 4, Executive Compensation, Brian Rusignuolo, Chief Information Officer